a GLP-1 drug stock<\/a>. Eli Lilly has taken the lead, but Novo Nordisk remains an important player in the new drug niche. Notably, it recently launched the first GLP-1 pill, which should help it regain market share from Eli Lilly, at least in the short term. People prefer pills over shots, for obvious reasons.<\/p>\n![\"Novo](\"https:\/\/www.newsbeep.com\/nz\/wp-content\/uploads\/2026\/02\/1772075048_371_.png\"\/)
<\/p>\n
Today’s Change<\/p>\n
(-1.21%) $-0.47<\/p>\n
Current Price<\/p>\n
$38.13<\/p>\n
Key Data Points<\/p>\n
Market Cap<\/p>\n
$130B<\/p>\n
Day’s Range<\/p>\n
$37.68 – $38.23<\/p>\n
52wk Range<\/p>\n
$37.65 – $91.90<\/p>\n
Volume<\/p>\n
2.2M<\/p>\n
Avg Vol<\/p>\n
22M<\/p>\n
Gross Margin<\/p>\n
80.90%<\/p>\n
Dividend Yield<\/p>\n
4.47%<\/p>\n
The takeaway from Novo Nordisk’s development of a GLP-1 pill is that it remains an innovative drug maker. The excitement around weight-loss drugs is so high that investors may be overlooking the company’s long-term opportunities and fundamental business strengths. All Wall Street is seeing is the fact that Eli Lilly’s GLP-1 drugs are performing better in the market right now.<\/p>\n
Novo Nordisk’s strong core business and ongoing innovation in a newly developing drug niche suggest this financially strong dividend stock<\/a> is an attractive holding, no matter what the market is doing. Indeed, consumers are still going to need insulin during a bear market and people will probably still be looking to lose weight, too.<\/p>\n","protected":false},"excerpt":{"rendered":"Although pegged as a weight-loss stock, this drug maker’s core business has long been diabetes. Novo Nordisk (NVO…\n","protected":false},"author":2,"featured_media":302431,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[134,524,111,139,69],"class_list":["post-302430","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-health","tag-medication","tag-new-zealand","tag-newzealand","tag-nz"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/302430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=302430"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/302430\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/302431"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=302430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=302430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=302430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"A](\"https:\/\/www.newsbeep.com\/nz\/wp-content\/uploads\/2026\/02\/1772075048_962_.jpeg\"\/)
<\/p>\n